COMPANY

History of EWHA Pharmtek Corp.
History
of EWHA Pharmtek Corp..
2008 . 12 2008 EWHA president, Mr. Jung-Hyup,Lee received a certificate of commendation from Ministry for food, agriculture, forestry & fisheries by distinguished quarantine service.
2007 . 08 EWHA establishes an exclusive distributorship agreement for sangrovit with Phytobiotics(Germany)
2006 . 10 EWHA establishes and Vaccine Business agreement with DYNTEC (Czech Republic)
2003 . 07 Ewhapharmtek moves from incheon to Gimpo and equips GMP manufacturing facility. The new facility will reorganize the production of disinfectants, oral liquid solution, suspension, powder, granule and tablet forms of product and the storage. Good Manufacturing Practice certificate (KVGMP) was given by National Veterinary Research and Quarantine Service, Korea.
             . 01 EWHA establishes and exclusive distributorship agreement with interchemie (Netherlands)
2002 . 01 EWHA adopts new corporate identity of Ewha pharmtek Corp. EWHA introduces new products such as vaccine (CANVAC DHPPIL) and deodorant (PETSORB) and other pet-related products, Ewhapharmtek shows turnover of 7,500 million Won on the year.
1999 . 01 EWHA reches its total turnver of 5,000 million Won with a staff of 25 people and ranks 19th out of 60 veterinary manufacturers in Korea which include domestic companies as well as multinationals.
1995 . 01 EWHA expands into pharmaceuticals for flsh farming industry.
1992 . 01 EWHA becomes exclusive distributor for Hoechst Roussel's Veterinary and hormone products such as Iliren, Receptal, Regumate, Cobactan, etc.
1990 . 01 EWHA becomes exclusive distributor for Hoechst Roussel's Veterinary and hormone products such as Iliren, Receptal, Regumate, Cobactan, etc.
             . 01 EWHA establishes a distributor agreement with Hoechst for Korean market place for Panacur (a.k.a. Safe Guard in U.S.). Flavomycin and Panacur, are EWHA's leading products in rapidly growing Korean market for feed additives and livestock industry.
1983 . 01 EWHA moved its manufacturing facility to Incheon Korea. Additional partnerships are established with Goldschmidt (Now of Degussa). Schuelke & May (Germany) and Laboratories Biove (France).
1982 . 01 EWHA Pharmaceuficals changed its name to EWHA Pharma CO., Ltd. Capital is raised to 300 million Won. EWHA undergoes a major expansion of its commercial business bt setting up regional sales office throughout Korea. EWHA starts its manufacturing and distribution agreement with Hoechst AG(Germany) now of Intervet with product Flavomycin.
1977 . 01 Mr. Jung-Hyup Lee (B.S Kon. Kuk University) founded. EWHA Pharmaceuticals. EWHA receives the license to manufacture veterinary pharmaceuticals and feed additives from Korean ministry of Agriculture. Forest, and Fishery. EWHA becomes a member of Korean animal health producer association (link Http://www.kahpa.or.kr)

카피라이터 링크 영역입니다.